Beam Therapeutics Inc (BEAM)
$27.93 -$0.31 (-1.11%) 10:11 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.31B -
Day's Range
$27.02 - $27.95 -
Volume
1,025,431 -
52 Week Low / High
$20.84 - $49.50 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 7
- Strong Buy
- 3
- Buy
- 8
- Hold
- 0
- Sell
- 0
- Strong Sell
- $67.00
- Target Price
Company News
-
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc — Oct 17th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 3,929,557 shares of Beam Therapeutics Inc (NASDAQ:BEAM), a pioneering biotechnology company. This transaction, executed at a price of $24.5 per ...
-
Suntory appoints EVP and founding family member Torii as president — Dec 12th, 2024
Japan's Suntory Holdings said on Thursday that Executive Vice President Nobuhiro Torii will become president next March, putting the food and beverage conglomerate back under the leadership of a founding family member....
-
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc — Oct 17th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 3,929,557 shares of Beam Therapeutics Inc (NASDAQ:BEAM), a pioneering biotechnology company. This transaction, executed at a price of $24.5 per ...
-
US lets Starlink provide direct-to-cell coverage for hurricane-hit areas — Oct 6th, 2024
The FCC often grants such emergency temporary approvals during disasters....
-
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc — Oct 17th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 3,929,557 shares of Beam Therapeutics Inc (NASDAQ:BEAM), a pioneering biotechnology company. This transaction, executed at a price of $24.5 per ...
-
US lets Starlink provide direct-to-cell coverage for hurricane-hit areas — Oct 6th, 2024
The FCC often grants such emergency temporary approvals during disasters....
-
US lets Starlink provide direct-to-cell coverage for hurricane-hit areas — Oct 6th, 2024
The FCC often grants such emergency temporary approvals during disasters....
-
US lets Starlink provide direct-to-cell coverage for hurricane-hit areas — Oct 6th, 2024
The FCC often grants such emergency temporary approvals during disasters....
-
US lets Starlink provide direct-to-cell coverage for hurricane-hit areas — Oct 6th, 2024
The FCC often grants such emergency temporary approvals during disasters....
-
US lets Starlink provide direct-to-cell coverage for hurricane-hit areas — Oct 6th, 2024
The FCC often grants such emergency temporary approvals during disasters....
-
US lets Starlink provide direct-to-cell coverage for hurricane-hit areas — Oct 6th, 2024
The FCC often grants such emergency temporary approvals during disasters....
-
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc — Oct 17th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 3,929,557 shares of Beam Therapeutics Inc (NASDAQ:BEAM), a pioneering biotechnology company. This transaction, executed at a price of $24.5 per ...
-
US lets Starlink provide direct-to-cell coverage for hurricane-hit areas — Oct 6th, 2024
The FCC often grants such emergency temporary approvals during disasters....
-
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc — Oct 17th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 3,929,557 shares of Beam Therapeutics Inc (NASDAQ:BEAM), a pioneering biotechnology company. This transaction, executed at a price of $24.5 per ...
-
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc — Oct 17th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 3,929,557 shares of Beam Therapeutics Inc (NASDAQ:BEAM), a pioneering biotechnology company. This transaction, executed at a price of $24.5 per ...
-
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc — Oct 17th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 3,929,557 shares of Beam Therapeutics Inc (NASDAQ:BEAM), a pioneering biotechnology company. This transaction, executed at a price of $24.5 per ...
-
US lets Starlink provide direct-to-cell coverage for hurricane-hit areas — Oct 6th, 2024
The FCC often grants such emergency temporary approvals during disasters....
-
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc — Oct 17th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 3,929,557 shares of Beam Therapeutics Inc (NASDAQ:BEAM), a pioneering biotechnology company. This transaction, executed at a price of $24.5 per ...
-
Suntory appoints EVP and founding family member Torii as president — Dec 12th, 2024
Japan's Suntory Holdings said on Thursday that Executive Vice President Nobuhiro Torii will become president next March, putting the food and beverage conglomerate back under the leadership of a founding family member....
-
Suntory appoints EVP and founding family member Torii as president — Dec 12th, 2024
Japan's Suntory Holdings said on Thursday that Executive Vice President Nobuhiro Torii will become president next March, putting the food and beverage conglomerate back under the leadership of a founding family member....
-
State Street Corp's Strategic Acquisition in Beam Therapeutics Inc — Oct 17th, 2024
Overview of the Recent Transaction On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 3,929,557 shares of Beam Therapeutics Inc (NASDAQ:BEAM), a pioneering biotechnology company. This transaction, executed at a price of $24.5 per ...
Portfolio
Comprised of 1 portfolios